Leaderboards/advanced breast cancer therapies

advanced breast cancer therapies

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Kevin Kalinsky
Emory University
70
2
Giuseppe Caruso
Mayo Clinic
60
3
Muralidhar Beeram
South Texas Accelerated Research Therapeutics
40
4
Dejan Juric
Massachusetts General Hospital
30
5
François‐Clément Bidard
Institut Curie
20
6
Gabe S. Sonke
The Netherlands Cancer Institute
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
M.P. Goetz
Mayo Clinic
90
2
M.F. Mosele
Inserm
80
3
Sheryl M. Gough
Arvinas (United States)
50
4
Antonio Llombart‐Cussac
MedSIR (Spain)
40

Emerging Leaders Papers

1
Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models
Clinical Cancer Research|2024
152 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Angelo Di Leo
National Cancer Center
99
2
Antonio Llombart‐Cussac
Universitair Ziekenhuis Leuven
90
3
Mia von Euler
AstraZeneca (United Kingdom)
80
4
Jon M. Wigginton
Bristol-Myers Squibb (United States)
70
5
Margaret Dugan
Universität Hamburg
60
6
Robert Leonard
National Cancer Centre Japan
50
7
Joyce O’Shaughnessy
Texas Oncology
40
8
Richard A. Gams
Breast Center
30
9
Richard D. Gelber
Dana-Farber Cancer Institute
20
10
R.D. Rubens
Breast Cancer Now
10

All-Time Leaders Papers

1
Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group
Journal of Clinical Oncology|2001
1k cit.

Indexing advanced breast cancer therapies Reagents

Citation data for reagents in this field is currently compiling.